TY - JOUR
T1 - Primary amenorrhea as a manifestation of polycystic ovarian syndrome in adolescents
T2 - A unique subgroup?
AU - Rachmiel, Marianna
AU - Kives, Sari
AU - Atenafu, Eshetu
AU - Hamilton, Jill
PY - 2008/6
Y1 - 2008/6
N2 - Objective: To compare clinical and metabolic features of adolescents having primary amenorrhea (PA) and polycystic ovarian syndrome (PCOS) with those having oligomenorrhea or secondary amenorrhea (OM/SA) and PCOS. Design: Retrospective case-control study. Setting: Endocrine Gynecology Clinic at The Hospital for Sick Children, Toronto, Ontario, Canada. Patients: Girls and young women aged 14 to 18 years having PA and PCOS (n=9) seen during a 2 1/2-year period were compared with control subjects having OM/SA and PCOS (n=18) randomly selected during the same period. Intervention: Medical record review was performed to assess clinical, biochemical, and ultrasonographic measures, as well as response to a progesterone challenge. Main Outcome Measures: Differences in response to the progesterone challenge, hyperandrogenism, and the presence of features of the metabolic syndrome. Results: Compared with adolescents having OM/SA, adolescents having PA demonstrated older age at pubarche, higher androstenedione levels, greater prevalence of family history of obesity, a tendency toward no withdrawal bleeding in response to the progesterone challenge, and more features associated with the metabolic syndrome (acanthosis nigricans, higher diastolic blood pressure, and lower high-density lipoprotein cholesterol level). No significant correlation was demonstrated between response to the progesterone challenge, metabolic features, and androstenedione levels. Conclusion: Adolescents with PA and PCOS exhibit increased features of the metabolic syndrome and higher androstenedione levels and may represent a more severe spectrum of a common condition.
AB - Objective: To compare clinical and metabolic features of adolescents having primary amenorrhea (PA) and polycystic ovarian syndrome (PCOS) with those having oligomenorrhea or secondary amenorrhea (OM/SA) and PCOS. Design: Retrospective case-control study. Setting: Endocrine Gynecology Clinic at The Hospital for Sick Children, Toronto, Ontario, Canada. Patients: Girls and young women aged 14 to 18 years having PA and PCOS (n=9) seen during a 2 1/2-year period were compared with control subjects having OM/SA and PCOS (n=18) randomly selected during the same period. Intervention: Medical record review was performed to assess clinical, biochemical, and ultrasonographic measures, as well as response to a progesterone challenge. Main Outcome Measures: Differences in response to the progesterone challenge, hyperandrogenism, and the presence of features of the metabolic syndrome. Results: Compared with adolescents having OM/SA, adolescents having PA demonstrated older age at pubarche, higher androstenedione levels, greater prevalence of family history of obesity, a tendency toward no withdrawal bleeding in response to the progesterone challenge, and more features associated with the metabolic syndrome (acanthosis nigricans, higher diastolic blood pressure, and lower high-density lipoprotein cholesterol level). No significant correlation was demonstrated between response to the progesterone challenge, metabolic features, and androstenedione levels. Conclusion: Adolescents with PA and PCOS exhibit increased features of the metabolic syndrome and higher androstenedione levels and may represent a more severe spectrum of a common condition.
UR - http://www.scopus.com/inward/record.url?scp=44649114707&partnerID=8YFLogxK
U2 - 10.1001/archpedi.162.6.521
DO - 10.1001/archpedi.162.6.521
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 18524741
AN - SCOPUS:44649114707
SN - 1072-4710
VL - 162
SP - 521
EP - 525
JO - Archives of Pediatrics and Adolescent Medicine
JF - Archives of Pediatrics and Adolescent Medicine
IS - 6
ER -